Literature DB >> 11642427

Adductor spasmodic dysphonia and botulinum toxin treatment: the effect on well-being.

T P Langeveld1, F Luteijn, M van Rossum, H A Drost, R J Baatenburg de Jong.   

Abstract

Adductor spasmodic dysphonia (AdSD) is a controversial and enigmatic voice disorder. It is generally accepted that it has a neurologic, although undetermined, cause, and it is accompanied by much psychological and physical distress. In this prospective study, standardized psychometric tests were used to assess the personality characteristics and psychological and somatic well-being of 46 patients with AdSD. Moreover, the effect of botulinum toxin (Botox) treatment on their well-being was evaluated. No significant differences could be detected between patients and a representative norm group concerning 7 personality characteristics. Nevertheless, before treatment, there were significantly more psychological and somatic complaints. After establishment of a normal to near-normal voice with Botox injections, these complaints were reduced to normal levels--a finding suggesting these phenomena to be secondary to the voice disorder. These findings, and the normal personality characteristics, do not support a psychogenic cause of AdSD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11642427     DOI: 10.1177/000348940111001009

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  2 in total

1.  The consequences of spasmodic dysphonia on communication-related quality of life: a qualitative study of the insider's experiences.

Authors:  Carolyn R Baylor; Kathryn M Yorkston; Tanya L Eadie
Journal:  J Commun Disord       Date:  2005 Sep-Oct       Impact factor: 2.288

2.  The psychosocial consequences of BOTOX injections for spasmodic dysphonia: a qualitative study of patients' experiences.

Authors:  Carolyn R Baylor; Kathryn M Yorkston; Tanya L Eadie; Nicole C Maronian
Journal:  J Voice       Date:  2006-03-29       Impact factor: 2.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.